SCHEMBL1389929

SCHEMBL1389929

Cc1cc(/C(CC(c2ccc(-c3ccc(C(=O)O)cc3F)cc2)c2ccccc2C)=N\O)ccn1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPBAR1 Q8TDU6 6/20 0.80
▸ FAAH O00519 1/20 0.39
▸ CTSA P10619 3/20 0.39
▸ RARB P10826 1/20 0.37
▸ ADH5 P11766 2/20 0.37
▸ AKR1C3 P42330 2/20 0.36
▸ AKR1C2 P52895 2/20 0.36
▸ LMNA P02545 3/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ NPSR1 Q6W5P4 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ PTGS1 P23219 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ PTGS2 P35354 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ FABP2 P12104 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ AKR1C4 P17516 1/20 0.35
▸ ADRA2B P18089 1/20 0.35
▸ CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL363345 1.00 GPBAR1 (0.80) GPBAR1FAAHCTSARARBADH5
SCHEMBL10240968 1.00 GPBAR1 (0.80) GPBAR1FAAHCTSARARBADH5
SCHEMBL363921 0.92 GPBAR1 (0.70) GPBAR1FAAHCTSALMNASMN1; SMN2
SCHEMBL10240967 0.92 GPBAR1 (0.70) GPBAR1FAAHCTSALMNASMN1; SMN2
SCHEMBL364422 0.92 GPBAR1 (0.70) GPBAR1FAAHCTSALMNASMN1; SMN2
SCHEMBL15949019 0.89 GPBAR1 (0.62) GPBAR1FAAHCTSARARBADH5
SCHEMBL10240955 0.89 GPBAR1 (1.00) GPBAR1CTSAPSEN1PSEN2APH1B
SCHEMBL364196 0.89 GPBAR1 (1.00) GPBAR1CTSAPSEN1PSEN2APH1B
SCHEMBL1389585 0.89 GPBAR1 (1.00) GPBAR1CTSAPSEN1PSEN2APH1B
SCHEMBL364261 0.89 GPBAR1 (1.00) GPBAR1CTSAPSEN1PSEN2APH1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP claimed
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885FAAH 1160/4885CTSA 3225/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback